Navigation Links
Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations
Date:11/3/2008

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and development of Diplomat's Chicago location and will closely collaborate with the executive team to develop and implement specialty pharmacy programs. Dr. Patel will directly report to Jeff Rowe, Sr. Vice President of Operations for Diplomat.

"Rinku brings extensive expertise in several key growth areas for Diplomat including RSV, Hemophilia, and Pharmacy technology," said Phil Hagerman, President and CEO of Diplomat Specialty Pharmacy. "Her experience in these core Specialty Pharmacy areas will support our continued national expansion and industry leading platform."

"I am thrilled to be part of Diplomat. They are the largest independently owned specialty pharmacy in the country and value patient care above everything else," said Dr. Patel. "I am looking forward to providing innovative and comprehensive specialty pharmacy solutions to address the needs of our Patients, Payors, Providers and Pharma partners."

Dr. Patel is a registered pharmacist with over 10 years of operational and strategic development experience in the areas of Specialty, Home Infusion, and Pharmacy Technology. Prior to joining Diplomat she was the Director of Procurement & Pharma Relations at OptionCare; and at Caremark, Dr. Patel was the Manager of Contracts and Trade Relations and served as an IT Pharmacist. Dr. Patel is a graduate of the Bachelors in Pharmacy and Doctor of Pharmacy programs at Midwestern University in Downers Grove, Illinois.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest independently held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

kkarns@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
2. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
3. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
4. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
5. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
6. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
7. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
8. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. A Perfect Storm Threatens Patient Access to Specialty Medical Care
11. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... , Feb. 4, 2016 Beike Biotechnology, the ... medical institutions attended a ceremony in late 2015 to ... cell therapy in 2016. --> ... Translation Platform for Personalized Cell Therapy" was hosted by ... Production Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... 4, 2016 Strasbourg, France ... --> Strasbourg, France , to the ... PharmaVentures is pleased to announce that it acted as an ... unit in Strasbourg, France , to the ... --> --> Transgene (Euronext: TNG), a member ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
(Date:2/1/2016)... YORK , Feb. 1, 2016  Today, the ... Association (AHA) announced plans to develop a first of ... computing power of IBM Watson. In the first application ... AHA, IBM (NYSE: IBM ), and Welltok will ... and health assessments with cognitive analytics, delivered on Welltok,s ...
Breaking Biology News(10 mins):